Paul Owen to Lead YourBio Health as New CEO
Investor - People | Feb 19, 2025 | Flagship Pioneering Inc
Paul Owen has been appointed as the CEO-Partner at Flagship Pioneering and the Chief Executive Officer of YourBio Health. This strategic recruitment aims to augment YourBio Health's innovative technology in remote blood collection. Owen has an extensive background in healthcare leadership, previously working as Board Director and President of Oncodea and in various roles at companies like Trusted Health Advisors, imaware, and OneOme. YourBio Health, founded by Flagship Pioneering in 2011, is recognized for its Touch-Activated Phlebotomy (TAP) device, which offers a pioneering push-button blood collection method designed to improve patient experience by reducing the discomfort and logistical complexity traditionally associated with phlebotomy. Under Owen's leadership, the company aims to expand the application of its TAP technology across clinical trials, diagnostics, and laboratory settings, maintaining partnerships with top biopharmaceutical and research organizations. Flagship Pioneering continues to innovate and foster bioplatform companies with a substantial financial footprint, driving advancements in human health and sustainability.
Sectors
- Medical Devices
- Biotechnology
- Healthcare
Geography
- United States – The companies and key individuals, such as Flagship Pioneering and YourBio Health, are based in the United States.
- Massachusetts – The headquarters of Flagship Pioneering and YourBio Health are located in Cambridge, Massachusetts.
Industry
- Medical Devices – The article focuses on YourBio Health, which produces the TAP device, a medical device designed for blood collection.
- Biotechnology – Flagship Pioneering is a bioplatform innovation company that supports biotechnological advancements, having founded biotech companies like Moderna and Foghorn Therapeutics.
- Healthcare – The article features a focus on healthcare solutions with YourBio Health's technology aimed at improving patient experience and clinical applications.
Financials
- $14 billion – Assets under management by Flagship Pioneering.
- $60 billion – Aggregate value generated by Flagship Pioneering through its ventures.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Flagship Pioneering | Private Equity Firm | Company | A bioplatform innovation company with a portfolio of companies transforming human health. |
| YourBio Health | Target Company | Company | A company focused on deploying its innovative TAP device for blood collection across multiple medical applications. |
| Paul Owen | Newly Appointed CEO | Person | Appointed as CEO of YourBio Health and CEO-Partner at Flagship Pioneering, with 35 years of experience in healthcare leadership. |